✦ LIBER ✦

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Scribed by Rossella Medori; J. Antoni Ramos-Quiroga; Miguel Casas; J.J.S. Kooij; Asko Niemelä; Götz-Erik Trott; Emma Lee; Jan K. Buitelaar

Book ID: 119197770
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 120 KB
Volume: 63
Category: Article
ISSN: 0006-3223
DOI: 10.1016/j.biopsych.2007.11.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theres 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Efficacy of reboxetine in adults with at

Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial

✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

A controlled trial of methylphenidate in

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

✍ Pieter J. Carpentier; Cor A. J. De Jong; Boukje A. G. Dijkstra; Cor A. G. Verbru 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

A randomised, placebo-controlled, 24-wee

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

✍ Michael Rösler; Roland Fischer; Richard Ammer; Claudia Ose; Wolfgang Retz; on be 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

A randomised, placebo-controlled, 24-wee

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

✍ Michael Rösler; Roland Fischer; Richard Ammer; Claudia Ose; Wolfgang Retz; on be 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 82 KB

Bupropion for adults with attention-defi

Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials

✍ Narong Maneeton; Benchalak Maneeton; Manit Srisurapanont; Stephen D. Martin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB